CoChat

Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study

Open access
Tromp, Tycho R, Hartgers, Merel L, Hovingh, G Kees, Vallejo-Vaz, Antonio J, Ray, Kausik K, Soran, Handrean, Freiberger, Tomas, Bertolini, Stefano, Harada-Shiba, Mariko, Blom, Dirk J, Raal, Frederick J, Cuchel, Marina, Tromp, Tycho R., Hartgers, Merel L., Hovingh, G. Kees, Vallejo-Vaz, Antonio J., Ray, Kausik K., Soran, Handrean, Freiberger, Tomas, Bertolini, Stefano A., Harada-Shiba, Mariko, Pang, Jing, Watts, Gerald F., Greber-Platzer, Susanne, Mäser, Martin, Stulnig, Thomas M., Ebenbichler, Christoph F., Bin Thani, Khalid, Cassiman, David, Descamps, Olivier S., Rymen, Daisy, Witters, Peter, Santos, Raul D., Brunham, Liam R., Francis, Gordon A., Genest, Jacques, Hegele, Robert A., Kennedy, Brooke A., Ruel, Isabelle, Sherman, Mark H., Jiang, Long, Wang, Luya, Reiner, Željko, Blaha, Vladimir, Ceska, Richard, Dvorakova, Jana, Dlouhy, Lubomir, Horak, Pavel, Soska, Vladimir, Tichy, Lukas, Urbanek, Robin, Vaverkova, Helena, Vrablik, Michal, Zemek, Stanislav, Zlatohlavek, Lukas, Emil, Sameh, Naguib, Tarek, Reda, Ashraf, Béliard, Sophie, Bruckert, Eric, Gallo, Antonio, Elisaf, Moses S., Kolovou, Genovefa, Cohen, Hofit, Durst, Ronen, Dann, Eldad J., Elis, Avishay, Hussein, Osama, Leitersdorf, Eran, Schurr, Daniel, Setia, Nitika, Verma, Ishwar C., Alareedh, Mohammed D., Al-Khnifsawi, Mutaz, Abdalsahib Al-Zamili, Ali F., Rhadi, Sabah H., Shaghee, Foaad K., Arca, Marcello, Averna, Maurizio, Bartuli, Andrea, Bucci, Marco, Buonuomo, Paola S., Calabrò, Paolo, Calandra, Sebastiano, Casula, Manuela, Catapano, Alberico L., Cefalù, Angelo B., Cicero, Arrigo F.G., D'Addato, Sergio, D'Erasmo, Laura, Di Costanzo, Alessia, Fasano, Tommaso, Gazzotti, Marta, Giammanco, Antonina, Iannuzzo, Gabriella, Ibba, Anastasia, Negri, Emanuele A., Pasta, Andrea, Pavanello, Chiara, Pisciotta, Livia, Rabacchi, Claudio, Ripoli, Carlo, Sampietro, Tiziana, Sbrana, Francesco, Sileo, Fulvio, Suppressa, Patrizia, Tarugi, Patrizia, Trenti, Chiara, Zenti, Maria G., Hori, Mika, Ayesh, Mahmoud H., Azar, Sami T., Bitar, Fadi F., Fahed, Akl C., Moubarak, Elie M., Nemer, Georges, Nawawi, Hapizah M., Madriz, Ramón, Mehta, Roopa, Cupido, Arjen J., Defesche, Joep C., Reijman, M. Doortje, Roeters-van Lennep, Jeanine E., Stroes, Erik S.G., Wiegman, Albert, Zuurbier, Linda, Al-Waili, Khalid, Sadiq, Fouzia, Chlebus, Krzysztof, Bourbon, Mafalda, Gaspar, Isabel M., Lalic, Katarina S., Ezhov, Marat V., Susekov, Andrey V., Groselj, Urh, Charng, Min-Ji, Khovidhunkit, Weerapan, Aktan, Melih, Altunkeser, Bulent B., Demircioglu, Sinan, Kose, Melis, Gokce, Cumali, Ilhan, Osman, Kayikcioglu, Meral, Kaynar, Leyla G., Kuku, Irfan, Kurtoglu, Erdal, Okutan, Harika, Ozcebe, Osman I., Pekkolay, Zafer, Sag, Saim, Salcioglu, Osman Z., Temizhan, Ahmet, Yenercag, Mustafa, Yilmaz, Mehmet, Yilmaz Yasar, Hamiyet, Mitchenko, Olena, Lyons, Alexander R.M., Stevens, Christophe A.T., Brothers, Julie A., Hudgins, Lisa C., Nguyen, Christina, Alieva, Rano, Shek, Aleksandr, Do, Doan-Loi, Kim, Ngoc-Thanh, Le, Hong-An, Le, Thanh-Tung, Nguyen, Mai-Ngoc T., Truong, Thanh-Huong, Blom, Dirk J., Raal, Frederick J., Cuchel, Marina · 2022 · The Lancet
Cited by 205

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Background: Homozygous familial hypercholesterolaemia (HoFH) is a rare inherited disorder resulting in extremely elevated low-density lipoprotein cholesterol (LDL-C) levels and premature atherosclerotic cardiovascular disease (ASCVD). Current guidance about its management and prognosis stems from relatively small studies, mostly from western countries. The objective of this study was to assess the clinical and genetic characteristics as well as the impact of current practice on health outcomes of HoFH patients globally. Methods: The HoFH International Clinical Collaborators (HICC) registry collected data on patients with a clinical and/or genetic diagnosis of HoFH using a retrospective cohort study design. Findings: Overall, 751 patients (52% female) from 38 countries were included, with 75% reporting bi-allelic pathogenic variants. Median age of diagnosis was 12∙0 (IQR 5∙5–27∙0) years, with major manifestations of ASCVD or aortic stenosis already present in 9% at diagnosis of HoFH. Globally, pre-treatment LDL-C levels were 14∙7 (IQR 11∙6–18∙4) mmol/L, with 92% of patients subsequently receiving statins, 64% ezetimibe and 39% lipoprotein apheresis. On-treatment LDL-C levels were lower in high-income versus non-high-income countries (3∙93 [IQR 2∙6–5∙8] versus 9∙3 [IQR 6∙7–12∙7] mmol/L), with greater use of three or more lipid-lowering therapies (LLT) (66% versus 24%) and consequently more patients attaining guideline-recommended LDL-C goals (21% versus 3% respectively). A first major adverse cardiovascular event occurred a decade earlier in non-high-income countries, at a median age of 24∙5 (IQR 17∙0–34∙5) versus 37∙0 (IQR 29∙0–49∙0) years in high-income countries (adjusted hazard ratio: 1∙64 [95%CI 1∙13–2∙38]). Interpretation: Worldwide, patients with HoFH are diagnosed too late, undertreated and at high premature ASCVD risk. Greater use of multi-LLT regimens associates with lower LDL-C levels and better outcomes. Significant global disparities exist in treatment regimens, control of LDL-C levels and cardiovascular event-free survival, which demands a critical re-evaluation of global health policy to reduce inequalities and improve outcomes for all patients with HoFH. Study registration: ClinicalTrials.gov NCT04815005 (link) Funding: Detailed at end of paper (see Acknowledgements).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(21)02001-8

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 205

Metadata

Authors
Tromp, T. R., Hartgers, M. L., Hovingh, G. K., Vallejo-Vaz, A. J., Ray, K. K., Soran, H., Freiberger, T., Bertolini, S., Harada-Shiba, M., Blom, D. J., Raal, F. J., Cuchel, M., Tromp, T. R., Hartgers, M. L., Hovingh, G. K., Vallejo-Vaz, A. J., Ray, K. K., Soran, H., Freiberger, T., Bertolini, S. A., Harada-Shiba, M., Pang, J., Watts, G. F., Greber-Platzer, S., Mäser, M., Stulnig, T. M., Ebenbichler, C. F., Bin Thani, K., Cassiman, D., Descamps, O. S., Rymen, D., Witters, P., Santos, R. D., Brunham, L. R., Francis, G. A., Genest, J., Hegele, R. A., Kennedy, B. A., Ruel, I., Sherman, M. H., Jiang, L., Wang, L., Reiner, Ž., Blaha, V., Ceska, R., Dvorakova, J., Dlouhy, L., Horak, P., Soska, V., Tichy, L., Urbanek, R., Vaverkova, H., Vrablik, M., Zemek, S., Zlatohlavek, L., Emil, S., Naguib, T., Reda, A., Béliard, S., Bruckert, E., Gallo, A., Elisaf, M. S., Kolovou, G., Cohen, H., Durst, R., Dann, E. J., Elis, A., Hussein, O., Leitersdorf, E., Schurr, D., Setia, N., Verma, I. C., Alareedh, M. D., Al-Khnifsawi, M., Abdalsahib Al-Zamili, A. F., Rhadi, S. H., Shaghee, F. K., Arca, M., Averna, M., Bartuli, A., Bucci, M., Buonuomo, P. S., Calabrò, P., Calandra, S., Casula, M., Catapano, A. L., Cefalù, A. B., Cicero, A. F. G., D'Addato, S., D'Erasmo, L., Di Costanzo, A., Fasano, T., Gazzotti, M., Giammanco, A., Iannuzzo, G., Ibba, A., Negri, E. A., Pasta, A., Pavanello, C., Pisciotta, L., Rabacchi, C., Ripoli, C., Sampietro, T., Sbrana, F., Sileo, F., Suppressa, P., Tarugi, P., Trenti, C., Zenti, M. G., Hori, M., Ayesh, M. H., Azar, S. T., Bitar, F. F., Fahed, A. C., Moubarak, E. M., Nemer, G., Nawawi, H. M., Madriz, R., Mehta, R., Cupido, A. J., Defesche, J. C., Reijman, M. D., Roeters-van Lennep, J. E., Stroes, E. S. G., Wiegman, A., Zuurbier, L., Al-Waili, K., Sadiq, F., Chlebus, K., Bourbon, M., Gaspar, I. M., Lalic, K. S., Ezhov, M. V., Susekov, A. V., Groselj, U., Charng, M.-J., Khovidhunkit, W., Aktan, M., Altunkeser, B. B., Demircioglu, S., Kose, M., Gokce, C., Ilhan, O., Kayikcioglu, M., Kaynar, L. G., Kuku, I., Kurtoglu, E., Okutan, H., Ozcebe, O. I., Pekkolay, Z., Sag, S., Salcioglu, O. Z., Temizhan, A., Yenercag, M., Yilmaz, M., Yilmaz Yasar, H., Mitchenko, O., Lyons, A. R. M., Stevens, C. A. T., Brothers, J. A., Hudgins, L. C., Nguyen, C., Alieva, R., Shek, A., Do, D.-L., Kim, N.-T., Le, H.-A., Le, T.-T., Nguyen, M.-N. T., Truong, T.-H., Blom, D. J., Raal, F. J., & Cuchel, M.
Venue
The Lancet
Publisher
Elsevier BV
Published
2022-02
Volume
399
Issue
10326
Pages
719-728
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W4210272691
Cited by
205
References
7
FWCI
36.03
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study. https://app.cochat.ai/papers/10.1016/s0140-6736(21)02001-8
The paper
Tromp, T. R., Hartgers, M. L., Hovingh, G. K., Vallejo-Vaz, A. J., Ray, K. K., Soran, H., Freiberger, T., Bertolini, S., Harada-Shiba, M., Blom, D. J., Raal, F. J., Cuchel, M., Tromp, T. R., Hartgers, M. L., Hovingh, G. K., Vallejo-Vaz, A. J., Ray, K. K., Soran, H., Freiberger, T., . . . Cuchel, M. (2022). Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study. The Lancet. https://doi.org/10.1016/s0140-6736(21)02001-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.